Press Releases ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-03 EDT			5-day change	1st Jan Change
67.25 ^USD	+0.21%		+2.89%	+21.96%

05-03	Ani Pharmaceuticals Insider Sold Shares Worth $1,332,400, According to a Recent SEC Filing	MT
04-17	Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences	05-01	AQ
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	04-18	AQ
ANI Pharmaceuticals : Corporate Presentation - April 2024	04-17	PU
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	04-09	AQ
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	04-04	AQ
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	04-03	AQ
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	03-27	AQ
ANI Pharmaceuticals : Corporate Presentation - March 2024	03-12	PU
ANI: Q4 Earnings Snapshot	02-29	AQ
ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance	02-29	AQ
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference	02-20	AQ
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET	02-07	AQ
ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks \| 6th Annual Biotechnology Conference	01-29	AQ
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP	01-23	AQ
ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP	01-16	AQ
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference	11-22	AQ
ANI: Q3 Earnings Snapshot	11-08	AQ
ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance	11-08	AQ
ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences	23-10-30	AQ
ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET	23-10-25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Press Releases

Filters